₹1,937.30
+₹23.60 (+1.23%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹32,131 Cr
P/E
58.81
ROE
20.13%
ROCE
25.56%
About Dr Lal Pathlabs Ltd
Dr. Lal PathLabs engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology,
Founded
1995
CEO
Arvind Lal
Employees
5,611
HQ
Gurgaon, India
About Dr Lal Pathlabs Ltd
Dr. Lal PathLabs engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology,
Founded:1995
CEO:Arvind Lal
Employees:5,611
HQ:Gurgaon, India
Finished Products
1Sale of Services
₹12,255.63Cr2Other Operating Revenue
₹0.91CrRaw Materials
1Cost of Materials Consumed
₹2,228.37CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,989
52W Low
₹1,273
Volume134.26K
Avg VolumeN/A
Beta0.53
Dividend Yield1.07%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
58.81x
Valuation
P/B Ratio
12.81x
Valuation
EPS
₹32.55
Valuation
Dividend Yield
1.07%
Valuation
ROE
20.13%
Profitability
ROCE
25.56%
Profitability
Revenue by Segment
Contribution & growth by business line
Running laboratories for carrying oRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
99.2%
International
0.8%
India99.2%
Outside India0.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.08x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
7.5%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.